Concomitant Retinal Alterations in Neuronal Activity and TNFα Pathway Are Detectable during the Pre-Symptomatic Stage in a Mouse Model of Alzheimer’s Disease

Abstract

The pre-symptomatic stage of Alzheimer’s disease (AD) is associated with increased amyloid-β (Aβ) precursor protein (APP) processing and Aβ accumulation in the retina and hippocampus. Because neuronal dysfunctions are among the earliest AD-related alterations, we asked whether they are already detectable in the retina during the pre-symptomatic stage in a APPswePS1dE9 (APP/PS1) mouse model. The age chosen for the study (3–4 months) corresponds to the pre-symptomatic stage because no retinal Aβ was detected, in spite of the presence of βCTF (the first cleavage product of APP). We observed an increase in ERG amplitudes in APP/PS1 mice in comparison to the controls, which indicated an increased retinal neuron activity. These functional changes coincided with an increased expression of retinal TNFα and its receptors type-1 (TNFR1). Consistently, the IkB expression increased in APP/PS1 mice with a greater proportion of the phosphorylated protein (P-IkB) over total IkB, pointing to the putative involvement of the NFkB pathway. Because TNFα plays a crucial role in the control of neuronal excitability, it is likely that, as in the hippocampus, TNFα signaling via the TNFR1/NFkB pathway may be also involved in early, AD-associated, retinal neuron hyperexcitability. These results further demonstrate the interest of the retina for early disease detection with a potential to assess future therapeutic strategies.

Multiple Bioenergy-Linked OCT Biomarkers Suggest Greater-Than-Normal Rod Mitochondria Activity Early in Experimental Alzheimer's Disease

“… 60 , 62 , 86 , 87 A prodromal contrast sensitivity decline has been reported in the transgenic APP SWE /PS1 ∆E9 murine model of AD. 63 , 88 In this study, we observed for the first time a decline in visual contrast sensitivity without visual acuity problems in 5xFAD mice at 4 months of age. As previously reported, the two visual performance indices studied here do not always change together in other experimental models.…”

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy

“…Animal models of amyloidosis are the most widely used in the domain of AD. For instance, in aged APP/PS1 mice, the a- and b-wave scotopic responses were found to be altered [ 14 , 48 ]. Similar abnormalities of the visual system were observed in 5xFAD models [ 10 ].…”

Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment

“…Inflammatory mediators like IL1β, IL6 and TNF-α have also been implicated in AD progression. Mechanisms underlying early neuronal dysfunctions and transient synaptic hyperexcitability involve the increase in TNFα during the early stage of AD [36][37][38]. Elevated levels of TNF-α in the hippocampus are associated with neuroinflammation and memory impairment in AD mice models [36,39].…”